BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Joglekar AV, Sandoval S. Pseudotyped Lentiviral Vectors: One Vector, Many Guises. Human Gene Therapy Methods 2017;28:291-301. [DOI: 10.1089/hgtb.2017.084] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Khakurel A, Kudlyk T, Lupashin VV. Generation and Analysis of hTERT-RPE1 VPS54 Knock-Out and Rescued Cell Lines. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2639-9_22] [Reference Citation Analysis]
2 Bui S, Li J, Stark D, Houmani A, Wang Y. Generation of Stable Cell Lines Expressing Golgi Reassembly Stacking Proteins (GRASPs) by Viral Transduction. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2639-9_24] [Reference Citation Analysis]
3 Raguram A, Banskota S, Liu DR. Therapeutic in vivo delivery of gene editing agents. Cell 2022;185:2806-27. [PMID: 35798006 DOI: 10.1016/j.cell.2022.03.045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
4 Soldierer M, Bister A, Haist C, Thivakaran A, Cengiz SC, Sendker S, Bartels N, Thomitzek A, Smorra D, Hejazi M, Uhrberg M, Scheckenbach K, Monzel C, Wiek C, Reinhardt D, Niktoreh N, Hanenberg H. Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies. Front Immunol 2022;13:847008. [PMID: 35464442 DOI: 10.3389/fimmu.2022.847008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Deng L, Liang P, Cui H. Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy? Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.03.007] [Reference Citation Analysis]
6 ) JSE, Janošťáková A, Das V, Kudlová N, Stránská J, Buriánová R, Kotulová J, Schadich E, Ondra M, Kubíčková A, Gurská S, Flodrová P, Flodr P, Kurfürstová D, Kořínková G, Gachechiladze M, Buchtová T, Mistrík M, Trojanec R, Šporiková Z, Řehulka J, Ligasová A, Koberna K, Stanková J, Frydrych I, Agrawal K, Lacey M, Škrott Z, Mašek V, Medvedíková M, Gurský J, Džubák P, De Sanctis JB, Hrubá L, Václavková J, Holub D, Oždian T, Jakoubková M, Petřík M, Nový Z, Annadurai N, Carazo A, Lišková B, Koudeláková V, Uniyal V, Drábek J, Macečková Z, Slavík H, Srovnal J, Řehulková A, Bartáková K, Slavkovský R. Laboratory Techniques in Cellular and Molecular Medicine. 2022. [DOI: 10.5507/lf.22.24460499] [Reference Citation Analysis]
7 Suresh R, Megagiannis P, Chen H, Landman R, Sharma J, Zhou Y. Genetic Engineering of Nonhuman Primate Models for Studying Neurodevelopmental Disorders. Neuromethods 2022. [DOI: 10.1007/978-1-0716-2569-9_12] [Reference Citation Analysis]
8 Shaburova EV, Lanshakov DA. Effective Transduction of Brain Neurons with Lentiviral Vectors Purified via Ion-Exchange Chromatography. Appl Biochem Microbiol 2021;57:890-8. [DOI: 10.1134/s0003683821080044] [Reference Citation Analysis]
9 Huckaby JT, Landoni E, Jacobs TM, Savoldo B, Dotti G, Lai SK. Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells. J Immunother Cancer 2021;9:e002737. [PMID: 34518288 DOI: 10.1136/jitc-2021-002737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Skukan L, Brezak M, Ister R, Klimaschewski L, Vojta A, Zoldoš V, Gajović S. Lentivirus- or AAV-mediated gene therapy interventions in ischemic stroke: A systematic review of preclinical in vivo studies. J Cereb Blood Flow Metab 2021;:271678X211039997. [PMID: 34427147 DOI: 10.1177/0271678X211039997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Sampson AT, Heeney J, Cantoni D, Ferrari M, Sans MS, George C, Di Genova C, Mayora Neto M, Einhauser S, Asbach B, Wagner R, Baxendale H, Temperton N, Carnell G. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. Viruses 2021;13:1579. [PMID: 34452443 DOI: 10.3390/v13081579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mirow M, Schwarze LI, Fehse B, Riecken K. Efficient Pseudotyping of Different Retroviral Vectors Using a Novel, Codon-Optimized Gene for Chimeric GALV Envelope. Viruses 2021;13:1471. [PMID: 34452336 DOI: 10.3390/v13081471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Freen-van Heeren JJ. Exploiting HIV-1 tropism to target CD4+ T cells for CRISPR. Immunol Cell Biol 2021;99:677-9. [PMID: 34231252 DOI: 10.1111/imcb.12487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhan W, Muhuri M, Tai PWL, Gao G. Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens? Front Immunol 2021;12:673699. [PMID: 34046041 DOI: 10.3389/fimmu.2021.673699] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Russell AL, Prince C, Lundgren TS, Knight KA, Denning G, Alexander JS, Zoine JT, Spencer HT, Chandrakasan S, Doering CB. Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII. Mol Ther Methods Clin Dev 2021;21:710-27. [PMID: 34141826 DOI: 10.1016/j.omtm.2021.04.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Gong Y, Klein Wolterink RGJ, Wang J, Bos GMJ, Germeraad WTV. Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy. J Hematol Oncol 2021;14:73. [PMID: 33933160 DOI: 10.1186/s13045-021-01083-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
17 Schellinger IN, Dannert AR, Mattern K, Raaz U, Tsao PS. Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease. Front Cardiovasc Med 2021;8:571076. [PMID: 33937351 DOI: 10.3389/fcvm.2021.571076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Lee S, Kim YY, Ahn HJ. Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector. Biomaterials 2021;272:120793. [PMID: 33836291 DOI: 10.1016/j.biomaterials.2021.120793] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
19 Tran HTT, Le NPK, Gigl M, Dawid C, Lamy E. Common dandelion (Taraxacum officinale) efficiently blocks the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614, mutants D614G, N501Y, K417N and E484K in vitro.. [DOI: 10.1101/2021.03.19.435959] [Reference Citation Analysis]
20 Toon K, Bentley EM, Mattiuzzo G. More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation. Viruses 2021;13:217. [PMID: 33572589 DOI: 10.3390/v13020217] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
21 Barklis E, Alfadhli A, Kyle JE, Bramer LM, Bloodsworth KJ, Barklis RL, Leier HC, Petty RM, Zelnik ID, Metz TO, Futerman AH, Tafesse FG. Ceramide synthase 2 deletion decreases the infectivity of HIV-1. J Biol Chem 2021;296:100340. [PMID: 33515546 DOI: 10.1016/j.jbc.2021.100340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Tani H, Kimura M, Tan L, Yoshida Y, Ozawa T, Kishi H, Fukushi S, Saijo M, Sano K, Suzuki T, Kawasuji H, Ueno A, Miyajima Y, Fukui Y, Sakamaki I, Yamamoto Y, Morinaga Y. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein. Virol J 2021;18:16. [PMID: 33435994 DOI: 10.1186/s12985-021-01490-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
23 Wang Y, Bruggeman KF, Franks S, Gautam V, Hodgetts SI, Harvey AR, Williams RJ, Nisbet DR. Is Viral Vector Gene Delivery More Effective Using Biomaterials? Adv Healthc Mater 2021;10:e2001238. [PMID: 33191667 DOI: 10.1002/adhm.202001238] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
24 Moreira AS, Cavaco DG, Faria TQ, Alves PM, Carrondo MJT, Peixoto C. Advances in Lentivirus Purification. Biotechnol J 2021;16:e2000019. [PMID: 33089626 DOI: 10.1002/biot.202000019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
25 Vrba SM, Kirk NM, Brisse ME, Liang Y, Ly H. Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats. Vaccines (Basel) 2020;8:E680. [PMID: 33202961 DOI: 10.3390/vaccines8040680] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
26 Zamorano Cuervo N, Grandvaux N. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife 2020;9:e61390. [PMID: 33164751 DOI: 10.7554/eLife.61390] [Cited by in Crossref: 169] [Cited by in F6Publishing: 181] [Article Influence: 56.3] [Reference Citation Analysis]
27 Kaygisiz K, Synatschke CV. Materials promoting viral gene delivery. Biomater Sci 2020;8:6113-56. [PMID: 33025967 DOI: 10.1039/d0bm01367f] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
28 Dautzenberg IJC, Rabelink MJWE, Hoeben RC. The stability of envelope-pseudotyped lentiviral vectors. Gene Ther 2021;28:89-104. [PMID: 32973351 DOI: 10.1038/s41434-020-00193-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
29 Tani H, Tan L, Kimura M, Yoshida Y, Yamada H, Fukushi S, Saijo M, Kawasuji H, Ueno A, Miyajima Y, Fukui Y, Sakamaki I, Yamamoto Y, Morinaga Y. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.. [DOI: 10.1101/2020.08.21.262295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Formas‐oliveira AS, Basílio JS, Rodrigues AF, Coroadinha AS. Overexpression of ER Protein Processing and Apoptosis Regulator Genes in Human Embryonic Kidney 293 Cells Improves Gene Therapy Vectors Production. Biotechnol J 2020;15:1900562. [DOI: 10.1002/biot.201900562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Tosolini AP, Sleigh JN. Intramuscular Delivery of Gene Therapy for Targeting the Nervous System. Front Mol Neurosci 2020;13:129. [PMID: 32765219 DOI: 10.3389/fnmol.2020.00129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
32 van Haasteren J, Li J, Scheideler OJ, Murthy N, Schaffer DV. The delivery challenge: fulfilling the promise of therapeutic genome editing. Nat Biotechnol 2020;38:845-55. [PMID: 32601435 DOI: 10.1038/s41587-020-0565-5] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 27.0] [Reference Citation Analysis]
33 Chiang CY, Ligunas GD, Chin WC, Ni CW. Efficient Nonviral Stable Transgenesis Mediated by Retroviral Integrase. Mol Ther Methods Clin Dev 2020;17:1061-70. [PMID: 32462054 DOI: 10.1016/j.omtm.2020.04.020] [Reference Citation Analysis]
34 Gouvarchin Ghaleh HE, Bolandian M, Dorostkar R, Jafari A, Pour MF. Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy. Biomed Pharmacother 2020;128:110276. [PMID: 32502836 DOI: 10.1016/j.biopha.2020.110276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
35 Toran PT, Wohlfahrt M, Foye J, Kiem HP, Wojchowski DM. Assessment and streamlined preparation of low-cytotoxicity lentiviral vectors for mobilized human hematopoietic stem cell transduction. Exp Hematol 2020;86:28-42.e3. [PMID: 32473295 DOI: 10.1016/j.exphem.2020.05.009] [Reference Citation Analysis]
36 Ikawa Y, Miccio A, Magrin E, Kwiatkowski JL, Rivella S, Cavazzana M. Gene therapy of hemoglobinopathies: progress and future challenges. Hum Mol Genet 2019;28:R24-30. [PMID: 31322165 DOI: 10.1093/hmg/ddz172] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
37 Hirbec H, Déglon N, Foo LC, Goshen I, Grutzendler J, Hangen E, Kreisel T, Linck N, Muffat J, Regio S, Rion S, Escartin C. Emerging technologies to study glial cells. Glia 2020;68:1692-728. [PMID: 31958188 DOI: 10.1002/glia.23780] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
38 Nóbrega C, Mendonça L, Matos CA. Viral Vectors for Gene Therapy. A Handbook of Gene and Cell Therapy 2020. [DOI: 10.1007/978-3-030-41333-0_3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Lanshakov D. Effective Transduction of Brain Neurons with Lentiviral Vectors Purified by Ion-Exchange Chromatography. Biiotehnologiâ (Mosk ) 2020;36:89-97. [DOI: 10.21519/0234-2758-2020-36-5-89-97] [Reference Citation Analysis]
40 Kriesel F, Stegmann L, Ciesek S, Kaderali L, Baldauf HM. Efficient inactivation of pseudotyped HIV-based lentiviral vectors and infectious HIV. J Virol Methods 2020;276:113768. [PMID: 31704112 DOI: 10.1016/j.jviromet.2019.113768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Kang Y, Chu C, Wang F, Niu Y. CRISPR/Cas9-mediated genome editing in nonhuman primates. Dis Model Mech 2019;12:dmm039982. [PMID: 31636095 DOI: 10.1242/dmm.039982] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
42 Lester S, Harcourt J, Whitt M, Al-Abdely HM, Midgley CM, Alkhamis AM, Aziz Jokhdar HA, Assiri AM, Tamin A, Thornburg N. Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies. Access Microbiol 2019;1:e000057. [PMID: 32974558 DOI: 10.1099/acmi.0.000057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
43 Lee M, Kim YS, Lee K, Kang M, Shin H, Oh JW, Koo H, Kim D, Kim Y, Kong DS, Nam DH, Lee HW. Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models. Cancers (Basel) 2019;11:E1090. [PMID: 31370279 DOI: 10.3390/cancers11081090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
44 Salata C, Calistri A, Alvisi G, Celestino M, Parolin C, Palù G. Ebola Virus Entry: From Molecular Characterization to Drug Discovery. Viruses 2019;11:E274. [PMID: 30893774 DOI: 10.3390/v11030274] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
45 Jamali A, Kapitza L, Schaser T, Johnston ICD, Buchholz CJ, Hartmann J. Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors. Mol Ther Methods Clin Dev 2019;13:371-9. [PMID: 30997367 DOI: 10.1016/j.omtm.2019.03.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
46 Fan W, Shao M, Zhang J, Jin G, Liu F, Xu F. A Hybrid Nanovector of Suicide Gene Engineered Lentivirus Coated with Bioreducible Polyaminoglycosides for Enhancing Therapeutic Efficacy against Glioma. Adv Funct Mater 2019;29:1807104. [DOI: 10.1002/adfm.201807104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
47 Hu S, Li M, Akkina R. Generation of High-Titer Pseudotyped Lentiviral Vectors. Methods in Molecular Biology 2019. [DOI: 10.1007/978-1-4939-9065-8_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
48 Chen YH, Keiser MS, Davidson BL. Viral Vectors for Gene Transfer. Curr Protoc Mouse Biol 2018;8:e58. [PMID: 30485696 DOI: 10.1002/cpmo.58] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 11.2] [Reference Citation Analysis]
49 Delgadillo-Gutiérrez K, Ribas-Aparicio RM, Jiménez-Alberto A, Aparicio-Ozores G, Castelán-Vega JA. Stability of retroviral pseudotypes carrying the hemagglutinin of avian influenza viruses under various storage conditions. J Virol Methods 2019;263:44-9. [PMID: 30347199 DOI: 10.1016/j.jviromet.2018.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
50 van Haasteren J, Hyde SC, Gill DR. Lessons learned from lung and liver in-vivo gene therapy: implications for the future. Expert Opin Biol Ther 2018;18:959-72. [PMID: 30067117 DOI: 10.1080/14712598.2018.1506761] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]